DJIA 16,360.85 98.29 0.60%
NASDAQ 4,055.12 20.96 0.52%
S&P 500 1,850.60 7.62 0.41%
market minute promo

13.85 0.54 (4.06%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VNDA $13.85 4.06%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.29
Previous Close $13.31
Daily Range $12.57 - $13.81
52-Week Range $4.41 - $19.25
Market Cap $464.0M
P/E Ratio -19.87
Dividend (Yield) $0.00 (0.0%)
Volume 294,678
Average Daily Volume 1,293,444
Current FY EPS -$1.29

Sector

Healthcare

Industry

Drugs

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website: http://www.vandapharmaceuticals.com/

News & Commentary

Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High

Vanda Reports Wider-than-Expected Loss - Analyst Blog

Vanda Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript

Vanda Pharmaceuticals' Q4 Loss Widens on Higher Expenses

Vanda Pharmaceuticals reduced R&D expenses by 41%, but a tripling in SG&A expenses combined with modest Fanapt growth caused its loss to widen by 20%.

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Short Interest Drops 15.5% For VNDA

Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming

3 Horrendous Health-Care Stocks This Week

Which health-care stocks had as lousy of a week as Broncos fans? Here are 3 big losers from the past few days.

See More VNDA News...

VNDA's Top Competitors

VNDA $13.85 (4.06%)
Current stock: VNDA
AMGN $115.78 (0.68%)
Current stock: AMGN
GILD $69.50 (1.95%)
Current stock: GILD
BIIB $291.00 (1.93%)
Current stock: BIIB